DEVELOPMENT AND VALIDATION OF THE RP-HPLC METHOD FOR ESTIMATION OF CILNIDIPINE IN RAT PLASMA

Authors

  • RAMANKIT JAISWAL University Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur 440033, Maharashtra, India https://orcid.org/0000-0003-2831-8830
  • RITA WADETWAR University Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur 440033, Maharashtra, India https://orcid.org/0000-0001-5661-2127

DOI:

https://doi.org/10.22159/ijpps.2022v14i10.45940

Keywords:

RP HPLC, Cilnidipine, Rat plasma, Development, Validation

Abstract

Objective: A simple, precise, accurate, robust, and reliable RP-HPLC technique for detecting cilnidipine in Wistar rat plasma was developed and validated.

Methods: The chromatographic separation was performed using the C-18 reverse phase column Oyster BDS Premium C18 column (4.6 × 150 mm, 5 µm particle size). The flow rate was set to 1.2 ml/min, and the chromatogram was recorded at 240 nm. The proposed method was validated in compliance with the International Conference on Harmonization (ICH) guidelines.

Results: The calibration curves plotted were found to be linear over the concentration range of 40-200 ng/ml in Wistar rat plasma, with a regression coefficient of R2>0.999, suggesting that the linearity was within limits. The LOD and LOQ of the present method were found to be 2.184 and 4.518 ng/ml, respectively. Drug extraction recoveries from Wistar rat plasma were found to be >98%.

Conclusion: Using Wistar rat plasma, a simple, fast, specific, accurate, and precise analytical approach was developed and validated. The technique was validated according to the ICH guidelines. The obtained results show that the suggested technique can be simply and effectively utilized for routine cilnidipine analysis in Wistar rat plasma.

Downloads

Download data is not yet available.

References

Lee KR, Chae YJ, Lee JH, Kim DD, Chong S, Shim CK. Quantification of cilnidipine in human plasma by liquid chromatography-mass spectrometry. J Liq Chromatogr Relat Technol. 2012;35(2):308-20. doi: 10.1080/ 10826076.2011.597078.

Pawar VT, Pawar SV, More HN, Kulkarni AS, Gaikwad DT. RP-HPLC method for simultaneous estimation of cilnidipine and chlorthalidone. Res J Pharm Technol. 2017;10(11):3990-6. doi: 10.5958/0974-360X.2017.00724.7.

Andhale SM, Nikalje AP. Simultaneous estimation of azilsartan and cilnidipine in bulk by RP-HPLC and assessment of its applicability in marketed tablet dosage form. Int J App Pharm. 2022;14(1):116-23. doi: 10.22159/ijap.2022v14i1.42208.

Ghante MR, Akhade A, Gota P, Nikam A, Jagtap S, Nikam V. Development and validation of high-performance thin-layer chromatography method for simultaneous estimation of nebivolol hydrochloride and cilnidipine. Asian J Pharm Clin Res. 2019;12(4):347-50. doi: 10.22159/ajpcr.2019.v12i4.30569.

Zhang X, Zhai S, Zhao R, Ouyang J, Li X, Baeyens WR. Determination of cilnidipine, a new calcium antagonist, in human plasma using high-performance liquid chromatography with tandem mass spectrometric detection. Anal Chim Acta. 2007;600(1-2):142-6. doi: 10.1016/j.aca.2006.11.072, PMID 17903476.

Manoranjani M. Assay method development and validation of cilnidipine and ramipril, characterization of its degradants by using LC-MS/MS. Int J App Pharm. 2022;14(2):276-85. doi: 10.22159/ijap.2022v14i2.43570.

Diwan R, Ravi PR, Pathare NS, Aggarwal V. Pharmacodynamic, pharmacokinetic and physical characterization of cilnidipine loaded solid lipid nanoparticles for oral delivery optimized using the principles of design of experiments. Colloids Surf B Biointerfaces. 2020;193:111073. doi: 10.1016/j.colsurfb.2020.111073. PMID 32388122.

Diwan R, Ravi PR, Agarwal SI, Aggarwal V. Cilnidipine loaded poly (ε-caprolactone) nanoparticles for enhanced oral delivery: optimization using DoE, physical characterization, pharmacokinetic, and pharmacodynamic evaluation. Pharm Dev Technol. 2021;26(3):278-90. doi: 10.1080/ 10837450.2020.1864643, PMID 33319618.

Pawar VT, Pawar SV, More HN, Kulkarni AS, Gaikwad DT. RP-HPLC method for simultaneous estimation of cilnidipine and chlorthalidone. Res J Pharm Technol. 2017;10(11):3990. doi: 10.5958/0974-360X.2017.00724.7.

Shaikh F, Patel M, Shelke S, Patel V, Jani D, Shinde G. Formulation, characterization, optimization, and pharmacokinetic evaluation of cilnidipine-loaded liquisolid compacts with improved dissolution and bioavailability. J Pharm Innov. 2022;17(2):1-22. doi: 10.1007/s12247-022-09651-z.

Sojitra RG, Chotaliya UJ. Analytical method development and validation for simultaneous estimation of fimasartan potassium trihydrate and cilnidipine in synthetic mixture by HPLC for the treatment of hypertension stage-II. Future J Pharm Sci. 2021;7(1):1-7.

Pn R, N D. Formulation, development, and characterization of cilnidipine loaded solid lipid nanoparticles. Asian J Pharm Clin Res. 2018;11(9):120-5. doi: 10.22159/ajpcr.2018.v11i9.24666.

Rathod RH, Patil AS, Shirkhedkar AA. Novel NP and RP-HPTLC in praxis for simultaneous estimation of chlorthalidone and cilnidipine in bulk and pharmaceutical formulation. Anal Chem Lett. 2018;8(6):862-71. doi: 10.1080/22297928.2018.1527252.

Rupareliya RH, Joshi HS, Ram VR, Dave PN, Khosla E. Stability indicating simultaneous validation of telmisartan and cilnidipine with forced degradation behavior study by RP-UPLC in tablet dosage form. Int J Pharm Qual Assur. 2016;7(3):39-45.

Lee KR, Chae YJ, Lee JH, Kim DD, Chong S, Shim CK. Quantification of cilnidipine in human plasma by liquid chromatography-mass spectrometry. J Liq Chromatogr Relat Technol. 2012;35(2):308-20. doi: 10.1080/10826076.2011.597078.

Chaudhari SR, Shirkhedkar AA. An investigative review for pharmaceutical analysis of 1,4-dihydropyridine-3,5-dicarboxylic acid derivative: cilnidipine. Crit Rev Anal Chem. 2021;51(3):268-77. doi: 10.1080/10408347.2020.1718483, PMID 32048875.

Dalvi AV, Uppuluri CT, Bommireddy EP, Ravi PR. Design of experiments-based RP – HPLC bioanalytical method development for estimation of Rufinamide in rat plasma and brain and its application in a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1102-1103:74-82. doi: 10.1016/j.jchromb.2018.10.014, PMID 30380466.

Tiwari B, Shirsat MK, Kulkarni A. Development and validation of stability indicating RP-HPLC method for estimation of cilnidipine. J Drug Delivery Ther. 2020;10(1):97-100. doi: 10.22270/jddt.v10i1.3846.

Satyavert, Gupta S, Nair AB, Attimarad M. Development and validation of a bioanalytical method for the determination of hydrazinocurcumin in rat plasma and organs by HPLC-UV. J Chromatogr B Analyt Technol Biomed Life Sci. 2020;1156:122310. doi: 10.1016/j.jchromb.2020.122310. PMID 32835908.

Reddy BKK, Sekhar KBC, Mohan CK. Bioanalytical method development and validation for the simultaneous determination of vildagliptin and telmisartan in rabbit plasma using RP-HPLC. J Pharm Res Int. 2021;33(1):76-86. doi: 10.9734/jpri/2021/v33i131141.

Siva Prasad S, Rao Anna V, Babu Kasimala B. Quality by design (QBD) based development and validation of an HPLC method for the estimation of lurasidone in pharmaceutical formulations. Crit Rev. 2020;18(7):2155-61.

Maljuric N, Otasevic B, Golubovic J, Krmar J, Zecevic M, Protic A. A new strategy for development of eco-friendly RP-HPLC method using corona charged aerosol detector and its application for simultaneous analysis of risperidone and its related impurities. Microchem J. 2020;153:1-9. doi: 10.1016/j.microc.2019.104394.

TSS, Babu N. Analytical method validation of gliclazide related substances by high-performance liquid chromatography method. Int J Curr Pharm Sci. 2022;4(14):36-41. doi: 10.22159/ijcpr.2022v14i4.1999.

Khosa A, Krishna KV, Saha RN, Dubey SK, Reddi S. A simplified and sensitive validated RP-HPLC method for determination of temozolomide in rat plasma and its application to a pharmacokinetic study. J Liq Chromatogr Relat Technol. 2018;41(10):692-7. doi: 10.1080/10826076.2018.1511803.

Pamu S, Subrahmanyam CS, Rao Patnaik KK. Bioanalytical method development and validation of valsartan in rabbit plasma. Int J Pharm. 2015;5(4):1360-4.

Venkatesh G, Majid MI, Ramanathan S, Mansor SM, Nair NK, Croft SL. Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of Buparvaquone in human and rabbit plasma: application to pharmacokinetic study. Biomed Chromatogr. 2008;22(5):535-41. doi: 10.1002/bmc.965, PMID 18205140.

Vikas A, Rashmin P, Mrunali P, Sandip M, Kaushik T. RP-HPLC method for quantitative estimation of efinaconazole in topical microemulsion and microemulsion-based-gel formulations and in the presence of its degradation products. Microchem J. 2020;155:1-7. doi: 10.1016/j.microc.2020.104753.

Sura RS, Cvs S, Rachamalla SS. Bioanalytical RP-HPLC method development and validation of clopidogrel bisulfate in Wistar rat plasma and its application to pharmacokinetic study. Int J App Pharm. 2022;14(1):106-11. doi: 10.22159/ ijap.2022v14i1.43328.

Patel D, Sawant KK. Oral bioavailability enhancement of acyclovir by self-micro emulsifying drug delivery systems (SMEDDS). Drug Dev Ind Pharm. 2007;33(12):1318-26. doi: 10.1080/03639040701385527, PMID 18097805.

Garg NK, Sharma G, Singh B, Nirbhavane P, Katare OP. Quality by design (QbD)-based development and optimization of a simple, robust RP-HPLC method for the estimation of methotrexate. J Liq Chromatogr Relat Technol. 2015;38(17):1629-37. doi: 10.1080/10826076.2015.1087409.

Reddy CS, Rao BT. Development and validation of a stability indicating related substances of trandolapril by RP-HPLC and its degradation. Int J App Pharm. 2021;13(5):115-21. doi: 10.22159/ijap.2021v13i5.42113.

Kapoor B, Gupta R, Gulati M, Singh SK, Khatik GL, Chawla M. High-performance liquid chromatography and liquid chromatography/mass spectrometry studies on stress degradation behavior of sulfapyridine and development of a validated, specific, stability-indicating HPLC assay method. Assay Drug Dev Technol. 2020;18(3):119-33. doi: 10.1089/adt.2019.959, PMID 32267712.

Kumar R, Kumar R, Khursheed R, Awasthi A, Khurana N, Singh SK. Development and validation of RP-HPLC method for estimation of fisetin in rat plasma. S Afr J Bot. 2021;140:284-9. doi: 10.1016/j.sajb.2020.05.010.

Devi PR, Rambabu K. Rapid determination of carboplatin and docetaxel using RP-HPLC with PDA detector. Int J Appl Pharm. 2022;14(2):186-92.

Published

01-10-2022

How to Cite

JAISWAL, R., and R. WADETWAR. “DEVELOPMENT AND VALIDATION OF THE RP-HPLC METHOD FOR ESTIMATION OF CILNIDIPINE IN RAT PLASMA”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 14, no. 10, Oct. 2022, pp. 32-37, doi:10.22159/ijpps.2022v14i10.45940.

Issue

Section

Original Article(s)